146 related articles for article (PubMed ID: 1970185)
1. Receptor binding of somatostatin-14 and somatostatin-28 in rat brain: differential modulation by nucleotides and ions.
Srikant CB; Dahan A; Craig C
Regul Pept; 1990 Feb; 27(2):181-94. PubMed ID: 1970185
[TBL] [Abstract][Full Text] [Related]
2. Effects of monovalent and divalent cations and of guanine nucleotides on binding of vasopressin to the rat mesenteric vasculature.
Larivière R; Schiffrin EL
Can J Physiol Pharmacol; 1987 Jun; 65(6):1171-81. PubMed ID: 2957041
[TBL] [Abstract][Full Text] [Related]
3. Regional distribution of somatostatin receptor affinity states in rat brain: effects of divalent cations and GTP.
Moyse E; Slama A; Videau C; de Angela P; Kordon C; Epelbaum J
Regul Pept; 1989 Dec; 26(3):225-34. PubMed ID: 2576146
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.
Srikant CB; Murthy KK; Patel YC
Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):339-44. PubMed ID: 1312325
[TBL] [Abstract][Full Text] [Related]
5. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
[TBL] [Abstract][Full Text] [Related]
6. Quantitative in vivo autoradiographic localization of [125I-Tyr11]somatostatin-14- and [Leu8,D-Trp22-125I-Tyr25]somatostatin-28-binding sites in rat brain.
Patel YC; Baquiran G; Srikant CB; Posner BI
Endocrinology; 1986 Nov; 119(5):2262-9. PubMed ID: 2876887
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
Schäfer R; Reiser G
Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
Siehler S; Zupanc GK; Seuwen K; Hoyer D
Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
[TBL] [Abstract][Full Text] [Related]
9. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
Galizzi JP; Fosset M; Lazdunski M
Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
[TBL] [Abstract][Full Text] [Related]
10. Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion.
Mazzoni MR; Martini C; Lucacchini A
Biochim Biophys Acta; 1993 Dec; 1220(1):76-84. PubMed ID: 8268248
[TBL] [Abstract][Full Text] [Related]
11. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
Murthy KK; Srikant CB; Patel YC
Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological characterization of somatostatin receptors in rat brain.
Sato H; Ota Z; Ogawa N
Res Commun Chem Pathol Pharmacol; 1989 Nov; 66(2):203-18. PubMed ID: 2574901
[TBL] [Abstract][Full Text] [Related]
13. Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.
Srikant CB; Heisler S
Endocrinology; 1985 Jul; 117(1):271-8. PubMed ID: 2861078
[TBL] [Abstract][Full Text] [Related]
14. Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway.
Felley CP; O'Dorisio TM; Howe B; Coy DH; Mantey SA; Pradhan TK; Sutliff VE; Jensen RT
Am J Physiol; 1994 May; 266(5 Pt 1):G789-98. PubMed ID: 7911277
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptors in Neuro2A neuroblastoma cells: operational characteristics.
Koenig JA; Edwardson JM; Humphrey PP
Br J Pharmacol; 1997 Jan; 120(1):45-51. PubMed ID: 9117097
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.
Thoss VS; Piwko C; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):648-60. PubMed ID: 8738298
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei.
Bucharles C; Vaudry H; Leroux P
Eur J Pharmacol; 1994 Dec; 271(1):79-86. PubMed ID: 7698215
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin binding and modulation of adenylate cyclase in ovine retina membranes.
Colás B; Valencia AM; Prieto JC; Arilla E
Mol Cell Endocrinol; 1992 Oct; 88(1-3):111-7. PubMed ID: 1360927
[TBL] [Abstract][Full Text] [Related]
19. Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors.
Reubi JC; Rivier J; Perrin M; Brown M; Vale W
Endocrinology; 1982 Mar; 110(3):1049-51. PubMed ID: 6120075
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of somatostatin receptors in the rat cerebellum during development.
Gonzalez BJ; Leroux P; Bodenant C; Braquet P; Vaudry H
J Neurochem; 1990 Sep; 55(3):729-37. PubMed ID: 1974603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
